Leidos (LDOS) Secures $318M Sole-Source Contract for MHS Genesis
Leidos (LDOS) won a $318M contract for MHS Genesis system support. GF Value™ suggests LDOS is 30.7% undervalued at $119.70 vs. $172.78 intrinsic value. GF Score™ of 85/100 highlights strong profitability and growth. Insiders sold $3.2M shares in 12 months, no purchases. Contract runs through January 2028, funded by FY2026 budget.
How this was made
The 30-second read
Why it matters
A $317.99M sole-source bridge award through January 2028 is a concrete procurement catalyst that can improve revenue visibility and reduce near-term execution risk for Leidos’ government IT segment.
Market read
Traders can treat this as a fresh, large federal contract disclosure that may affect expectations for government services revenue and backlog.
What to watch
The article does not provide contract margin, renewal probability, or total program economics, so investors may need to assess whether this award meaningfully improves earnings power versus funding continuity.
Background
MHS Genesis is an electronic health record system supporting US defense health operations, and the contract is positioned as a bridge to new service providers while maintaining operations.
Ticker impact
Leidos was awarded a sole-source bridge contract worth $317.99M to support MHS Genesis system reintegration, software licensing, and hosting through January 2028.
Likely upward bias as the market prices in incremental federal services revenue and continuity of the MHS Genesis program.
The article discloses a specific, large contract value, sole-source status, and multi-year performance window tied to Leidos’ core government IT services.
Market effects
Supports sentiment for defense IT and EHR modernization contractors, highlighting continued federal spend on health IT systems.
Work centered in Reston, Virginia, but likely limited broader regional market impact.
Primarily US defense health IT procurement, with limited direct global spillover.
Counterpoint
Sole-source bridge contracts can be transitional and may not translate into sustained long-term margin expansion beyond the bridge period.
Key entities
- companyLeidos Holdings Inc
US defense IT and systems integrator awarded the sole-source bridge contract for MHS Genesis support.
- programMHS Genesis
Electronic health record system supporting US defense operations, central to the contract scope.
- government agencyDefense Health Agency
Agency described as the cornerstone technology owner for MHS Genesis.


